Tsagaankhuu Guntev
Stroke Department, Shastin Third Central Hospital, Ulaanbaatar, MongoliaPublications
-
Research Article
Comparative Study of Intravenous Thrombolysis for Acute Ischemic Stroke in Mongolian Patients Aged Above and Below 50 Years
Author(s): Delgermaa Tsagaankhuu64610, Chimeglkham Banzrai64611, Tsagaankhuu Guntev64612* and Baigalmaa Gongor64613
Objective: The present study aimed to compare the safety and efficacy of Intravenous Thrombolysis (IVT) between Mongolian young and older patients with Acute Ischemic Stroke (AIS). Methods: Data of 115 AIS patients who received recombinant tissue Plasminogen Activator (rt-PA) between May 2013 and May 2023 at the Stroke Center of Third Central Hospital were retrospectively analyzed. Patients aged <50 years (n=31) compared with those aged ≥ 50 years (n=84) with regards to baseline characteristics, symptomatic Intracerebral Haemorrhage (sICH), functional outcomes at 3 months defined as “favorable” and “poor” (modified Rankin Scale score 0-2 vs. 3-6) including in-hospital mortality. Results: 27% of patients were <50 years old (54.8% males; mean age 42.7.. Read More»
DOI: 10.31858/0975-8453.14.12.757-761
Abstract
How to cite this article